Veli-Pekka Harjola Selected Research

Warfarin (Coumadin)

10/2014	Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
2/2014	High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
1/2014	Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".
6/2013	Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.
5/2013	Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veli-Pekka Harjola Research Topics

Disease

40	Heart Failure 01/2023 - 05/2006
27	Cardiogenic Shock 02/2024 - 05/2015
10	Myocardial Infarction 06/2022 - 03/2010
9	Stroke (Strokes) 01/2018 - 05/2013
8	Acute Coronary Syndrome 01/2021 - 01/2010
8	Atrial Fibrillation 01/2018 - 05/2013
6	Shock 10/2021 - 06/2005
6	Pulmonary Embolism 01/2021 - 05/2011
4	Heart Arrest (Cardiac Arrest) 08/2021 - 07/2016
4	Embolism (Embolus) 02/2015 - 05/2013
3	ST Elevation Myocardial Infarction 02/2024 - 11/2017
3	Hypotension (Low Blood Pressure) 10/2021 - 05/2015
3	Out-of-Hospital Cardiac Arrest 08/2021 - 03/2016
3	Hypothermia 08/2021 - 03/2016
3	Coma (Comas) 08/2021 - 03/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 08/2021 - 02/2013
3	Infarction (Infarctions) 01/2019 - 01/2010
2	Inflammation (Inflammations) 02/2024 - 06/2022
2	Wounds and Injuries (Trauma) 06/2022 - 01/2010
2	Acidosis 01/2021 - 03/2017
2	Takotsubo Cardiomyopathy 03/2020 - 01/2020
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2020 - 01/2020
2	Pulmonary Hypertension 03/2020 - 01/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 01/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 08/2007
2	Confusion (Bewilderment) 03/2017 - 05/2015
2	Hemorrhage 10/2014 - 06/2013
1	Acute Kidney Injury (Acute Renal Failure) 02/2021
1	Frailty 01/2021
1	Heart Diseases (Heart Disease) 03/2020
1	Chest Pain (Chest Pains) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Hypoalbuminemia 01/2019
1	Fatigue 12/2018
1	Lactic Acidosis 10/2018

Drug/Important Bio-Agent (IBA)

13	Simendan (Levosimendan)IBA 03/2020 - 01/2007
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2013
8	Lactic Acid (Lactate)FDA LinkGeneric 10/2021 - 05/2015
8	apixabanIBA 01/2018 - 05/2013
5	CreatinineIBA 01/2020 - 01/2007
5	CalciumIBA 12/2019 - 01/2007
5	Epinephrine (Adrenaline)FDA LinkGeneric 12/2019 - 07/2016
5	Warfarin (Coumadin)FDA LinkGeneric 10/2014 - 05/2013
4	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 07/2016
4	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 08/2007
4	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2019 - 04/2008
4	TroponinIBA 06/2016 - 08/2008
3	SodiumIBA 01/2023 - 03/2010
3	XenonIBA 08/2021 - 03/2016
3	Growth Differentiation Factor 15IBA 01/2021 - 11/2019
3	Troponin IIBA 01/2020 - 02/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 04/2008
2	RivaroxabanIBA 01/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2008
2	Factor Xa InhibitorsIBA 01/2021 - 01/2020
2	Cystatin CIBA 01/2020 - 08/2007
2	DiureticsIBA 12/2019 - 01/2019
2	CatecholaminesIBA 12/2019 - 01/2018
2	Dobutamine FDA LinkGeneric 12/2019 - 07/2016
2	Vasodilator Agents (Vasodilators)IBA 12/2019 - 01/2018
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2019 - 10/2018
2	Vasoconstrictor AgentsIBA 10/2018 - 09/2016
2	Potassium Channels (Potassium Channel)IBA 01/2018 - 12/2013
2	Troponin T (Troponin T1)IBA 11/2017 - 06/2005
2	Blood Glucose (Blood Sugar)IBA 01/2017 - 02/2013
1	human MIRN619 microRNAIBA 02/2024
1	empagliflozinIBA 01/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 06/2022
1	Furosemide (Lasix)FDA LinkGeneric 06/2021
1	proenkephalinIBA 02/2021
1	Lipocalin-2IBA 02/2021
1	C-Reactive ProteinIBA 01/2021
1	ProcalcitoninIBA 01/2021
1	procizumabIBA 01/2020
1	Insulin-Like PeptidesIBA 01/2020
1	Insulin-Like Growth Factor Binding Protein 4IBA 01/2020
1	Milrinone (Primacor)FDA LinkGeneric 12/2019
1	Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA 12/2019
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 12/2019
1	Dopamine (Intropin)FDA LinkGeneric 12/2019
1	UlaritideIBA 11/2019
1	ElectrolytesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Serum AlbuminIBA 01/2019
1	AlbuminsIBA 01/2019
1	Oxygen (Dioxygen)IBA 12/2018
1	PotassiumIBA 03/2018

Therapy/Procedure

9	Therapeutics 01/2020 - 09/2013
5	Critical Care (Surgical Intensive Care) 03/2020 - 01/2008
4	Percutaneous Coronary Intervention 01/2021 - 04/2017
2	Length of Stay 01/2021 - 01/2019
2	Artificial Respiration (Mechanical Ventilation) 12/2020 - 03/2017
2	Counterpulsation (External Counterpulsation) 01/2020 - 01/2020
2	Noninvasive Ventilation 01/2018 - 03/2017
2	Resuscitation 05/2015 - 01/2008
1	Extracorporeal Membrane Oxygenation 11/2022
1	Catheters 12/2020
1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2020